Skip to content
DataLookout
Menu

NCT07928947

Lactium Versus Midazolam Premedication on Postoperative Negative Behavioral Changes

StatusRecruiting
PhasePhase 2/3
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below.

  1. Notable Recruitment opened Show 5 more changesShow less
    • Start date changed from estimate of Nov 15, 2026 to Nov 12, 2026
    • Primary completion date: May 15, 2027 to May 12, 2027
    • Study completion date: Jun 15, 2027 to Jun 12, 2027
    • Secondary endpoints: details revised at 3 of 10 entries
    • Site details revised
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Incidence of negative behavioral changes at 24-h following surgery.
Timeframe: 24 hours after surgery.

Secondary (10)

Incidence of negative behavioral changes at 3, 7, 14, 30 days following surgery.
Incidence of emergence delirium.
Parent separation anxiety.
Mask acceptance.
Postoperative pain.
Show 5 moreShow less
Extubation time.
The total dose of rescue propofol.
The total dose of rescue fentanyl.
Anxiety scores.
Side effects.

Arms and interventions

Lactium groupExperimental

Cases will receive preoperative lactium (5 mg/kg). Each lentra sachet (containing 150 mg Lactium) will be totally dissolved in 60 ml water and (2 ml/kg) will be given to cases, 2 hours before surgery with a maximum dose of 300 mg.

Midazolam groupExperimental

Cases will receive preoperative 0.5 mg/kg oral midazolam (maximum 20 mg), 30 minutes before surgery.

Control groupPlacebo comparator

Cases will receive volume matched flavored solutions at each corresponding time point.

Drugs: Lactium, Midazolam

Other: Flavored oral solution

Sites

1 site in 1 country

  • Tanta University HospitalsTanta, Gharbia Governorate, Egypt